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Abstract Mutant rat trypsin AsplS9Ser was prepared and com- 
plexed with highly purified human al-proteinase inhibitor. The 
complex formed was purified to homogeneity and studied by 
N-terminal amino acid sequence analysis and limited proteolysis 
with bovine trypsin. As compared to uncomplexed mutant trypsin, 
the mutant enzyme complexed with oq-proteinase inhibitor 
showed a highly increased susceptibility to enzymatic digestion. 
The peptide bond selectively attacked by bovine trypsin was iden- 
tiffed as the ArgnT-Va111s one of trypsin. The structural and 
mechanistic relevance of this observation to serine proteinase- 
substrate and serine proteinase-serpin reactions are discussed. 
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1. Introduction 
According to Pauling's transition state theory [1], enzymes 
provide templates which are complementary to the reactants in 
their activated transition state rather than to the substrates in
their ground state. Despite 50-year extensive research along 
these lines the molecular mechanism by which enzymes convert 
substrates from the ground state to the transition state is not 
clear at all. It is generally accepted, however, that the structure 
of the enzyme must undergo some changes to complement 
changes of the substrate throughout catalytic reactions [24]. 
The extent of these changes may depend on the enzyme-sub- 
strate system studied, varying from an extensive distortion of 
the enzyme structure to complement transition state (induced 
fit) to relatively minor, local conformational changes in the 
course of catalysis [2-4]. In the case of serine proteinases, the 
latter mechanism seems to be likely, since the structures of 
crystalline trypsin and chymotrypsin are undistinguishable 
from those of the same enzymes complexed with 'substrate-like' 
canonical proteinase inhibitors [3 5]. The question, however, 
is whether the binding of these inhibitors does properly mimic 
substrate binding. Dufton [6] argued that the modes of interac- 
tion of inhibitors and substrates with the same serine proteinase 
might be markedly different, and that binding of true substrates 
to the proteinase, unlike that of inhibitors, might induce a 
relative movement of the two large domains in the enzyme. 
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phy; HPLC, high pressure liquid chromatography. 
According to this hypothesis, such movement would focus 
stress on the scissile bond in the substrate, thereby facilitating 
its hydrolysis [6]. Our own enzyme kinetic studies on trypsin, 
chymotrypsin and mutant trypsins with modified substrate- 
binding pockets further support he view that serine proteinase 
action may be accompanied by some conformational changes 
of the enzyme [7,8]. Our interpretation of the poor catalytic 
activity of mutant trypsins with chymotrypsin-like substrate- 
binding pockets has been that though the pockets properly 
accommodate the substrate, this interaction does not induce the 
conformational change crucial for optimal transition state sta- 
bilisation [7-10]. Furthermore, we hypothesised that different 
conformational flexibilities of the substrate-binding sites of 
trypsin and chymotrypsin, rather than evident differences be- 
tween the crystalline structures of the binding sites, represent 
the structural basis for the different substrate specificities of 
these proteinases [9,10]. Recently, this possibility has also been 
entertained by Perona and co-workers [11] when interpreting 
crystallographic data on two mutant rypsins with chymotryp- 
sin-like specificity. 
To directly explore the molecular mechanism of serine pro- 
teinase action time-resolved diffraction studies will be required. 
Until such studies will be technically feasible to be performed 
structural investigation of any kinetically stable reaction inter- 
mediates of serine proteinases may provide us with useful infor- 
mation about the extent and nature of conformational changes 
that the enzymes may undergo throughout catalysis. In this 
paper we present data on a dramatic onformational change of 
mutant trypsin Aspl89Ser upon its interaction with cq-pro- 
teinase inhibitor. 
2. Materials and methods 
2.1. Enzymes, inhibitors and chemicals 
Bovine pancreatic trypsin TPCK and porcine pancreatic elastase 
were purchased from Sigma. Mutant rat trypsinogens, Asp189Ser and 
His57Ala, Asp~°2Asn, were expressed in an E. coli expression-secretion 
system, purified to homogeneity and activated by enterokinase, as de- 
scribed previously [7,12]. Human cq-PI was obtained from Serva and 
purified to homogeneity on a MONO Q column (Pharmacia FPLC 
system, Uppsala, Sweden) by using a linear gradient from 0 to 0.5 M 
NaC1 in 10 mM sodium phosphate buffer, pH 7.0. Fractions were 
monitored by SDS-PAGE [13]. The purified inhibitor was stored at 
-20°C. All chemicals used were of reagent grade. 
2.2. Polyacrylamide gel electrophoresis and protein content 
determination 
SDS-PAGE was carried out in 12% or 15% (w/v) slab gels according 
to Laemmli [13]. Native non-denaturing PAGE was performed under 
the same conditions except hat SDS and 2-mercaptoethanol were ab- 
sent from the buffers and that he polyacrylamide gelconcentration was 
10% (w/v). Protein content was determined by the method of Bradford 
[14]. 
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2.3. Preparation and isolation of the mutant rypsin-otl-Pl complex 
~-PI in a slight molar excess was mixed with mutant rypsin 
Asp189Ser in 10 mM sodium phosphate buffer, at pH 7.0. The mixture 
was loaded onto a MONO Q column and eluted with a linear pH and 
salt gradient from 7.0 to pH 5.0 and from 0 to 0.2 M NaC1 in 10 mM 
sodium citrate-phosphate buffer. The separation was followed by SDS- 
PAGE [13]. The purified complex was stored at -20°C. 
2.4. Limited proteolysis 
Mutant trypsin Asp~SgSer and its complex with ~I-PI, in a final 
concentration f 4/.tM, in 0.2 mM sodium phosphate buffer of pH 7.0 
containing 0.1 M NaC1 were incubated with a 5 to 1 molar ratio of 
bovine trypsin. The digestion was performed at room temperature for 
different time periods from 0 to 16 h. Aliquots taken were boiled for 
3 min and then PMSF was added to them at a final concentration f 
1 mM. The samples were analysed by SDS-PAGE applying 15% and 
12% (w/v) polyacrylamide g ls for the mutant trypsin and the complex, 
respectively, and by N-terminal amino acid sequence analysis. 
2.5. Separation by HPLC 
Reversed-phase HPLC was used for the separation of fragments in
the intact and enzymatically degraded complexes. Samples were loaded 
onto an Aquapore OD300 C18 column (Applied Biosystems, 4.6 
mm x 220 mm) equilibrated with water containing 0.1% (v/v) TFA 
(solvent A), and a 30 min linear gradient was applied by using a mixture 
of 80% (v/v) acetonitrile, 20% (v/v) water and 0.08% (v/v) TFA, as 
solvent B. The flow rate was 1 ml/min and detection was done at 220 
nm.  
2.6. N-terminal amino acid sequence and amino acid analyses 
N-terminal amino acid sequences were determined in an Applied 
Biosystems 471 A pulsed liquid-phase s quencer by using a program 
adopted from Hunkapiller and co-workers [15]. Amino acid analysis 
was performed by Pico-Tag method [16]. 
3. Resul ts  
Human ~zl-proteinase inhibitor and mutant rat trypsin 
Asp~89Ser were mixed and the mixture was subjected to chro- 
matography on a MONO Q column as described in section 2. 
85% of the protein content of the mixture was eluted in one 
peak and found to be homogeneous by both SDS-PAGE and 
native non-denaturing PAGE (Figs. 1 and 2). The molecular 
weight of the mutant rypsin Asp189Ser--~-PI complex as esti- 
mated by SDS-PAGE (Fig. 1) is about 73 kDa, somewhat less 
than the sum of those of trypsin (24 kDa) and ~-PI  (53 kDa). 
Parallel experiments with wild-type rat trypsin and ~-PI  re- 
suited in similar esults, except hat the complex isolated from 
a b c 
Fig. 1. 12% SDS PAGE of (a) trypsin mutant Asp189Ser, (b) cq-PI and 
(c) purified trypsin mutant Asp~*gSer-~-PI complex. 
a b c d e 
Fig. 2. 10% native PAGE of trypsin mutants (a) Aspl89Ser and (b) 
His57Ala, Aspl°2Asn, (c) cq-PI, the equimolar mixtures of cq-PI with (d) 
trypsin mutant Asp~89Ser, and (e) trypsin mutant His57Ala, Asp~°2Asn. 
their mixture was less homogeneous and stable than that of 
mutant rypsin Asp189Ser-~l-PI (data not shown). 
A rat trypsin mutant with destroyed catalytic triad, mutant 
His57Ala, Asp~°2Asn [12] was not able to form stable complex 
with ~I-PI as shown by native PAGE (Fig. 2). 
To compare the structural flexibilities of mutant trypsin 
Asp~89Ser in complex with ~I-PI and in its uncomplexed form, 
both preparations were digested with bovine trypsin. SDS- 
PAGE was used to follow the time-course of the digestion (Fig. 
3). As seen in the Figure, the complex is much more susceptible 
to proteolysis than the trypsin mutant is in its uncomplexed 
form. In fact, the protein band of mutant rypsin-al-PI com- 
plex was converted to a new electrophoretic component within 
15 min, while mutant trypsin showed resistance totryptic diges- 
tion. It has to be noted that the presence of the cleaved form 
of ~I-PI appeared in these gels as a consequence of the 3 min 
boiling of samples. 
Sequences of the first six N-terminal residues of ~I-PI, tryp- 
sin mutant AspXS9Ser, the isolated mutant rypsin-~l-PI com- 
plex and a 1-h tryptic hydrolysate of the latter one were deter- 
mined, and the results are shown in Table 1. The N-terminus 
of ~-PI  is probably blocked since no amino acids could be 
detected in the first six cycles of Edman degradation. Sequenc- 
ing the isolated complex, in addition to the N-terminal sequence 
of the mutant trypsin anew amino acid sequence appeared that 
corresponds to residues 359-364 of cq-PI. PTH-amino acid 
signals for the two sequences were found to be comparable in
each cycle indicating that cq-PI was completely cleaved at pep- 
tide bond Met358-Ser 359. The separation and identification of 
the C-terminal fragment, residues 359-394, of ~-PI  (Peak I in 
Fig. 4A, Table 1) by reversed-phase chromatography [17] of the 
mutant trypsin--~x-PI complex confirmed this finding. N-termi- 
nal sequence analysis of a 1-h tryptic digest of the trypsin 
mutant--~l-PI complex revealed the presence, in equimolar 
amounts, of three N-terminal sequences (Table 1). The new 
N-terminal sequence released by limited tryptic hydrolysis of 
the complex is Val-Ala-Thr-Val-Ala-Leu-, representing the 
118-123 sequence region of rat trypsin. When the 1-h tryptic 
digest of the mutant rypsin--a~-PI complex was subjected to 
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Fig. 3. Limited proteolysis with bovine trypsin of rat trypsin mutant 
Asp189Ser-0q-PI complex (12% SDS-PAGE; panel A) and of rat trypsin 
mutant Asp l89Ser (15% SDS-PAGE; panel B). 4/aM complex and 4/zM 
mutant trypsin were incubated with 0.8/.tM bovine trypsin at pH 7 (0.1 
M NaCI, 0.2 M sodium phosphate buffer), at room temperature for 
different time periods (0-16 h). Aliquots removed at the indicated times 
(h) were boiled for 3 min and then PMSF was added at 1 mM final 
concentration to inactivate trypsin, nd (not digested) is the control 
sample which was incubated for 16 h under similar conditions but 
without bovine trypsin. T: trypsin mutant Asp~89Ser (Mw 24 kDa); T*: 
C-terminal fragment of cleaved trypsin mutant (Mw 13 kDa); C: trypsin 
mutant Asp189Ser--~l-PI complex without he C-terminal fragment of 
cz~-PI (Mw 73 kDa); C*: digested complex (Mw 62 kDa); I*: cleaved 
cq-PI (without its C-terminal fragment; Mw 49 kDa). 
reversed-phase HPLC, the newly released N-terminal fragment 
of the trypsin mutant coeluted with the C-terminal fragment of 
~I-PI (Peak I in Fig. 4B, Table l) 
Schematic representation f the structures of trypsin mu- 
tant-~l-PI complex and its trypsin-nicked form is based on the 
protein analytical work described above (Fig. 5). 
4. Discuss ion 
The exact molecular mechanism by which serpins including 
~,-proteinase inhibitor interact with serine proteinases has not 
yet been established [18,19]. Since the reactive sites of serpins 
are susceptible to their target proteinases just like those of true 
substrates and 'substrate-like' canonical proteinase inhibitors, 
the general kinetic mechanism of their reaction with the en- 
zymes can be written as follows: 
181 
E + I ¢=> E • I <=> E-  I---> E - I* ~ E + I* 
Scheme 1 
where E. I is the initially formed Michaelis complex, E =- I is 
the tetrahedral complex (TI) and E -  I* is the acyl-enzyme 
intermediate that dissociates into the active enzyme (E) and the 
cleaved inhibitor (I*). The inhibitory mechanism of serpins 
differs, however, in many respects from that of canonical 
'standard mechanism' inhibitors like kunins and kazals [18,19]. 
One striking difference is that the structure of serpins unlike 
that of canonical inhibitors, while reacting with the proteinases, 
undergo a dramatic hange from a stressed, labile conforma- 
tion to a relatively ordered, heat-stable form [18,19,20]. Fur- 
thermore, serpins unlike canonical proteinase inhibitors form 
kinetically stable complexes with proteinases [21,22]. The ques- 
tion if the general structure of such complexes corresponds to 
a tetrahedral [22] or an acyl-enzyme intermediate [19,21] is still 
debated. 
Our own sequencing data on the mutant rypsin AsplS9Ser - 
cq-PI complex showed that the PI-PI' peptide bond was present 
in a cleaved form (Table 1, Fig. 4), thus supporting the view that 
the acyl-enzyme intermediate rather than the tetrahedral one 
may be the kinetically stable form of the complex. There may 
be some faint doubt, however, that the acyl intermediate was 
formed from the tetrahedral one under the conditions of 
phenyl-thiocarbamylation of the protein (first reaction of the 
Edman-degradation). Model experiments to exclude or confirm 
this possibility are now being performed in our laboratory. Our 
failure to form a stable complex between c(1-PI and mutant 
trypsin His57Ala, Asp~°2Asn further confirms the general notion 
that the catalytic apparatus of the proteinase is essential for 
complex formation with serpins [18,19,21,22]. 
Instead of native trypsin, a mutant rypsin with a single 
amino acid replacement in its substrate-binding pocket, Asp 189 
to Ser [7], was used in this work. The low (auto)catalytic a tiv- 
ity, 5 orders of magnitude smaller than that of wild-type tryp- 
sin, made this mutant an apparently ideal model to study the 
biochemical properties of the enzyme-~x-PI complex. Since the 
X-ray structure of mutant rat trypsin Asp189Ser complexed with 
Table 1 
Results of the N-terminal mino acid sequence analysis of (1) c~-PI, (2) 
trypsin mutant Asp~89Ser, (3) trypsin mutant Asp~89Ser--cq-PI complex, 
(4) complex digested with bovine trypsin for 1 h and (5) HPLC peaks 
in Fig. 4 (for details ee text) 
Sample No. of cycles 
1 2 3 4 5 6 
(1) cq -P I  . . . . .  
(2) Trypsin mutant I V G G Y T 
(3) Complex I V G G Y T 
S I P P E V 
(4) Digested complex I V G G Y T 
S I P P E V 
V A T V A L 
(5) HPLC peaks: 
peak I/Fig. 4A S I P P E V 
peak II/Fig. 4A I V G G Y T 
peak I/Fig. 4B I V G G Y T 
S I P P E V 
peak II/Fig. 4B V A T V A L 
The amino acids identified in the first six cycles are shown. 
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Fig. 5. Schematic representation of the structures ofmutant trypsin-~: 
PI and its trypsin-nicked form. 
bovine pancreatic trypsin inhibitor was shown to be identical 
with that of bovine trypsin complexed with the same inhibitor 
[23] there is no reason to doubt that structural features of the 
mutant rypsin Asp~89Ser-~:PI complex are relevant to natu- 
rally formed proteinase-serpin complexes. 
Though a relatively increased sensitivity of different pro- 
teinase-serpin complexes to proteolytic attack has already been 
noted in the literature [24,25], the cleavage sites within the 
complexes have not yet been identified. For the first time, our 
present studies provide vidence that the proteinase component 
of a proteinase-serpin complex underwent a dramatic onfor- 
mational change upon complex formation with the serpin, and 
that this increased molecular flexibility of the enzyme serves as 
the structural basis for the marked susceptibility ofthe complex 
to proteolytic attack. The tryptic cleavage site identified as 
peptide bond Argl17-Val l s in trypsin is of particular interest. 
This site is located within the hinge region connecting the two 
large domains of trypsin, the relative movement of which was 
postulated to play a crucial role in the catalytic process [6]. 
Considering the rational possibility that our mutant trypsin-~: 
PI represents either the acyl-enzyme or the tetrahedral interme- 
diate of the proteinase-serpin reaction we would be tempted to 
propose that the proteinase might undergo a similar conforma- 
tional transition when reacting with its true substrate. How- 
ever, other possibilities have to be also entertained. Such possi- 
bilities are that only serpins can induce such a conformational 
distortion of target proteinases or that they just reinforce cata- 
lytically relevant structural changes of proteinases. Such 
changes of the enzyme structure would complement, atcertain 
<-- 
F ig .  4. Reversed-phase HPLC analysis of (A) intact complex, (B) com- 
plex digested with bovine trypsin for 1 h, injected under educing con- 
ditions (2% v/v 2-mercaptoethanol), HPLC analysis was performed on 
a C18 reversed-phase column using a linear gradient of 0-80% acetoni- 
trile in 0.1% (v/v) aqueous TFA over 30 min at a flow rate of 1 ml/min. 
Peaks were identified by N-terminal amino acid sequence and amino 
acid analyses (Table 1). Peak I in (A) is the C-terminal fragment of 
C~I-PI, (Ser359-Lys394) ;  peak II in (A) is the trypsin mutant Asp189Ser--~: 
PI complex without he C-terminal fragment of ~:PI; peak I in (B) 
contains the C-terminal fragment of ~:PI (Sera59-Lys 394) and the N- 
terminal fragment of trypsin mutant AsplSgSer (lie 16 Arg117); peak II 
in (B) is the trypsin mutant Asp~89Ser-~:PI complex without he N- 
terminal fragment of trypsin (Ile16-Arg 117) and the C-terminal fragment 
of ~:PI (Ser359-Lys394) .  
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stages of the proteinase-serpin i teraction, the remarkable 
structural transition of serpins from a stressed conformation to
a relaxed one. 
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